News
The Commission launched a new call for advanced health approaches to rapidly respond to COVID-19
On 19 May the European Commission launched a new call for an Expression of Interest with a budget of €56 million for advanced health approaches to rapidly respond to COVID-19 and to deliver results for a higher level of preparedness of health systems.
Members of the European Parliament call for supporting health policies and health systems in the next Multiannual Financial Framework
On 1 May Members of the European Parliament (MEPs) sent a letter to Ursula von der Leyen, President of the European Commission, and Charles Michel, President of the European Council, calling to ensure the support of health policies and health systems in the next EU’s long-term budget for 2021-2027, also called the “Multiannual Financial Framework” (MFF).
Launch of the European COVID-19 Data Platform
On 20 April the Commission together with EU Member States and several partners, including EMBL’s European Bioinformatics Institute (EMBL-EBI) and research partners such as ELIXIR, launched a European COVID-19 Data Platform to enable the collection and sharing of reference data and specialised datasets to accelerate COVID-19 research.
The European Medicines Agency (EMA) published its Regulatory Science Strategy to 2025
On 31 March, the European Medicines Agency (EMA) published its Regulatory Science Strategy to 2025. The new RSS sets out the EMA’s strategic thinking for the advancement of regulatory science over the next five years, incorporating human as well as veterinary medicines.
Avicenna Alliance continues to grow by welcoming Servier among its members
The Avicenna Alliance is happy to welcome its newest member: Servier.
The Avicenna Alliance published new case studies on in silico medicine
The Avicenna Alliance is proud to announce that new Member’s case studies on in silico medicine have been published today!
